{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-23-000058","form_type":"8-K","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.028407+00:00","generated_at":"2026-06-13T01:58:11.002521+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Labcorp Q2 revenue $3.03B (+4% YoY); adjusted EPS $3.42 vs $4.04; completes Fortrea spin-off, launches $1B buyback","bullets":["Revenue from continuing ops $3.03B (+3.8% YoY); Base Business organic revenue +9.8% while COVID-19 testing declined -7.8% pts.","Diluted GAAP EPS $1.74 (down from $2.89); adjusted EPS $3.42 (down from $4.04); full-year adjusted EPS guidance $13.00-$14.00.","Completed spin-off of Fortrea on June 30; Fortrea distributed ~$1.6B cash; Labcorp announced $1.0B accelerated share repurchase.","New partnerships: lab agreement with Jefferson Health; acquisition of Providence Oregon outreach lab; Legacy Health inpatient lab management.","Q2 free cash flow $177M vs $408M; FY 2023 free cash flow guidance $0.8B-$1.0B; quarterly dividend $0.72/share payable Sept 8."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-23-000058","json":"https://secwatch.observer/filing/0000920148-23-000058.json","markdown":"https://secwatch.observer/filing/0000920148-23-000058.md","text":"https://secwatch.observer/filing/0000920148-23-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000058/0000920148-23-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000058/lh-20230727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T01:58:11.002521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49de35502d2e2069c27969e76027e4350a3d7e57","claim":"LABCORP HOLDINGS INC. reported Full Year 2023 results: EPS $13.00 to $14.00. Guidance initiated.","evidence_excerpt":"Full-Year 2023 Guidance from Continuing Operations: Adjusted EPS of $13.00 to $14.00 and Free Cash Flow of $0.8 billion to $1.0 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000058/0000920148-23-000058-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full Year 2023"},{"label":"EPS","value":"$13.00 to $14.00"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}